Zongertinib tablet study in healthy volunteers
This study tests how well the body absorbs a drug called zongertinib when it is given as tablets from two different manufacturers, with or without food. It helps researchers understand the best way to take the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- Your body mass index (BMI) must be between 18.5 and 29.9 kg/m².
- You must be in good health, as confirmed by a physical exam and routine lab tests.
- You must have normal blood pressure, pulse, and heart rhythm.
- You must be able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study is testing a new medicine called ZL-1503 in healthy volunteers to see how the body processes it and if it's safe. You may be able to join if you are in good health and meet certain age, weight, and lifestyle requirements.
This trial tests an experimental drug (zongertinib) for people with advanced solid tumors that have certain changes in the HER2 gene. It's for those who have already tried at least one standard treatment and need more options.
This study is testing a new medicine called ZE66-0205 for the first time in people. It is looking at healthy volunteers to see how the drug is processed by the body and if it is safe.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.